The question new operators ask is “which is cheaper?” The right question is “which makes my business work?”
Per-unit pricing is the easy comparison to run and the worst one to base your decision on. Once you account for restock cycles, customs risk, payment friction, communication overhead, and the cost of holding extra inventory because your supplier is on a 12-hour time-zone delay, the cheaper option on paper often ends up being the more expensive option in practice – especially for new operators moving small volumes.
This is the honest comparison we’d walk a friend through. No hand-waving, real numbers from real operations, and a clear framework for which path fits which kind of business.
The two real options
Strip away the marketing labels and there are really two paths:
US-Based Wholesale. A supplier that either manufactures domestically or maintains a US warehouse for distribution. You buy in bulk, they ship from the US to you in 2-3 days, you reship to your end customer. Per-pack pricing is 15-25% higher than Overseas Direct at comparable tiers.
Overseas Direct (almost always China). You buy in bulk from a Chinese manufacturer and they ship to you. Per-pack pricing is the lowest available in the market. Restock cycles are 10-15 days minimum. Customs risk is real and varies by destination country.
A few hybrid models exist – some operators source from one supplier in the US for high-volume SKUs and a separate overseas supplier for niche products – but the foundational decision is which of these two is your primary supply line.
The per-unit cost comparison
At the volumes a new operator is buying, here’s roughly what US-Based Wholesale looks like – this is our actual published tier pricing for BPC-157 5mg, a mid-tier mass-volume compound, as a concrete reference point.
| Tier | Per pack | Per vial | vs single-pack |
|---|---|---|---|
| 1 paquete | $200 | $20.00 | – |
| 5 paquetes | $130 | $13.00 | save 35% |
| 10 paquetes | $117 | $11.70 | save 42% |
| 25 paquetes | $105 | $10.50 | save 48% |
Overseas Direct typically runs 15-25% below comparable US-Based Wholesale at these volumes, depending on the supplier, the relationship, and the SKU. A founder buying 10 packs of a single SKU “saves” roughly $200-300 on that order by going overseas. That looks meaningful on a spreadsheet. The question is whether those savings survive the operational reality. Read on.
Restock time and what it actually costs you
This is the single biggest hidden cost of overseas sourcing and the one new operators consistently underestimate.
US-based supplier: order placed Monday, package arrives Wednesday or Thursday. You can run lean inventory because reorders are fast.
Overseas supplier: order placed Monday, package arrives 10-15 days later in the best case. Customs delays can stretch this to 3-4 weeks. You have to hold deep inventory to avoid stockouts on your bestsellers.
What “deep inventory” actually costs:
- A founder with $5,000 wholesale budget who wants 4 weeks of inventory floor can hold maybe 3-4 SKUs deep enough at overseas pricing. With US-based pricing they could hold the same 3-4 SKUs deep enough on a 1-week inventory floor and have $3,000 left to test 5-8 more SKUs.
- The cost of inventory depth isn’t just the cash tied up – it’s the SKU coverage you can’t afford. Operators who source overseas tend to have narrower catalogs because their working capital is locked in 4 weeks of stock per SKU.
The “stockout” cost is the most painful one. When your bestseller goes out of stock for 2-3 weeks while a China-sourced reorder clears customs, customers don’t wait. They search “BPC-157 wholesale” and order from your competitor. They don’t come back when you’re restocked. We’ve watched founders lose 30-40% of their customer base to a single bad stockout cycle in month four.
The customs problem
Most peptide imports clear US customs without issues. The ones that don’t are catastrophic.
Common patterns we’ve seen:
- Random border holds add 1-3 weeks to delivery with no recourse and no information
- Shipments occasionally get seized at the border. Carrier won’t tell you why; supplier shrugs
- Some compounds (the ones currently flagged by FDA or DEA as having abuse concerns) attract heavier customs scrutiny than others. Your supplier may not flag this to you upfront
- “Document-only” customs requests can require your business to produce import declarations you weren’t ready to file
- Destination countries other than the US (if you ever start shipping internationally yourself) have wildly different acceptance rates. Canada, Brazil, Singapore, and Australia all have specific customs friction with this category
For a brand-new operation, losing a single $5,000 order to customs seizure can be a business-ending event. For an established operation with cash reserves, it’s a frustrating quarterly tax. The risk doesn’t scale with your business – it’s most dangerous when you can least afford it.
US-based sourcing eliminates this risk entirely for US-to-US shipments. International retail shipping risk is still on your side of the equation regardless of where you sourced from, but the wholesale leg is clean.
Communication and the time-zone tax
This sounds soft. It’s not.
When you have an issue – a defective batch, a mis-shipped SKU, a payment dispute, a custom-label request, a question about COA dates – you need answers fast. Customer-support time is one of the largest hidden costs of running a peptide reseller business, and supplier-side friction multiplies it.
US-based: Email or call your sales rep at 11am, get an answer by 2pm same day. Issues resolve in one conversation. Time spent: 30-60 minutes.
Overseas (12-hour offset): Email your rep Monday morning, they read it Monday night their time, reply Tuesday morning your time. Their reply asks a clarifying question. You answer Tuesday afternoon, they reply Wednesday. Three days for an issue that should have been a 10-minute phone call.
This compounds. A reseller doing 50 orders/month is going to have 3-5 supplier-side issues a month at the steady state. Each one takes a US-based supplier 30 minutes and an overseas supplier 2-3 days to resolve. Over a year that’s 30-40 hours of overhead you didn’t budget for.
The communication delta also matters more when something is genuinely urgent. A 3-day customer dispute waiting on supplier confirmation feels like a week to the customer.
Payment friction
Overseas wholesale payments are international wires or crypto, occasionally Alipay or WeChat Pay for established relationships. International wires cost $25-50 per send, take 1-3 business days to settle, and are visible to your bank as foreign-merchant transactions – which can trigger account review flags if your bank’s risk department is paying attention. Some peptide operators we’ve worked with have had business bank accounts closed after a string of $5,000+ international wires to Chinese vendors.
US-Based Wholesale payments are ACH (free, 1-3 days), domestic wire ($15-25, same day), or business credit card if your supplier accepts it. No bank-flag risk, no currency conversion friction, no SWIFT delays.
This is a small but real cost difference per order. The bigger risk is the business-bank-account closure scenario – if it happens, you spend 4-6 weeks setting up a new banking relationship and your supplier orders stall during that window.
Cash flow impact
For most operators this is where the math actually breaks in favor of US-based sourcing.
Overseas scenario:
– Initial order: $5,000 (deeper inventory to absorb restock delay)
– Restock cycle: every 4 weeks
– Cash always tied up in stock: $5,000-7,000
US-based scenario:
– Initial order: $3,000 (leaner because restocks are fast)
– Restock cycle: every 1-2 weeks
– Cash always tied up in stock: $2,000-3,000
The difference – $3,000-4,000 of liberated working capital – is the same amount you’d spend on a meaningful ads test, a brand identity package, additional inventory diversity, or a runway buffer. For a founder operating on a $10,000-15,000 launch budget, this isn’t a rounding error. It’s the difference between testing demand on 8 SKUs vs 3 SKUs, or running ads vs not.
We talk through the full launch budget breakdown in our how to start a peptide company post if you want to see where that $3,000-4,000 of working capital should actually go.
When Overseas Direct actually makes sense
We’re not arguing overseas is always wrong – it isn’t. There are situations where the math favors it.
You’re moving 500+ packs per month of a small number of SKUs. At that volume the per-unit savings compound into real money ($5,000-10,000/month of pure margin difference), and you can afford the inventory depth to absorb a 4-week restock cycle. Most operators don’t reach this scale on their initial supplier – this is a year 2-3 decision, not a launch decision.
You’re building a niche specialty around compounds your US options don’t carry. Some less-common compounds (specific cosmetic peptides, certain research-only blends, niche cognitive compounds) have better coverage from overseas suppliers. If your differentiation is the catalog itself, overseas may be your only viable path for some SKUs.
You have existing customs experience and a brokerage relationship. Operators with prior import/export experience can mitigate the customs risk substantially. If you’ve already navigated US customs for other products, you know what to expect. If this is your first business dealing with imports, you’ll learn the hard way and pay for the education in delays and seizures.
You’re operating outside the US to begin with. EU and UK operators have different supplier-side economics than US-based ones. China-direct may be the natural answer if you’re not selling primarily into the US.
For 90%+ of new US-based operators, none of these apply, and US-Based Wholesale is the right answer.
What we’d actually recommend
The honest framework:
| Your situation | Recommendation |
|---|---|
| Brand new, US-based, under $20K launch budget | US-based supplier. Cash flow and customs risk favor US strongly at this scale. |
| 6-12 months in, US-based, $50-100K/month revenue | US-based primary + selective overseas for specialty SKUs. Mix model. |
| Year 2+, moving 500+ packs/mo of specific SKUs | Add Overseas Direct for those specific SKUs. Per-unit math finally works. |
| EU/UK/AU operator | Different equation entirely. Local suppliers if available; otherwise Overseas Direct or US shipped internationally – both have different risk profiles than the US-domestic case. |
How WWP fits both sides of this decision
Most posts comparing US vs overseas frame it as picking a side. We offer both paths under one supplier relationship, which is worth explaining since it changes the math.
WWP US-Based Wholesale is what most of our partners use. 2-3 day restock from the US warehouse, US sales team, no customs risk on the wholesale leg, ACH/wire payments, public COA library. Per-pack pricing is the table above. This is the default answer for any operator under year-two scale.
WWP Overseas Direct is available for partners who reach the volumes where per-unit savings actually compound (typically 500+ packs/month of specific SKUs, year 2+). Same compounds, same quality program, lower per-unit pricing. The tradeoff is the restock cycle and customs friction we just described above – those don’t go away just because you’re buying through us. What you do get versus going to a Chinese manufacturer cold: an English-speaking team that handles the supplier coordination for you, a known quality baseline, and the ability to move volume back to the US warehouse for any specific SKU if the overseas leg gets disrupted.
The practical advantage of the dual-supply model is that you don’t have to pick once and migrate later. A founder who launches on US-Based Wholesale and grows into Overseas Direct economics in year two doesn’t have to vet a new supplier, re-test quality consistency, or re-build a COA library – they just shift the supply path on specific SKUs while staying on the same account.
For most new operators, that means starting on US-Based Wholesale and not worrying about the overseas path until volume forces the question.
Frequently asked questions
Are peptides manufactured in the US?
Yes – several US-based peptide manufacturing operations exist, ranging from research-grade contract manufacturers to specialty in-house production facilities. The US-based supply chain is smaller than China’s by volume, but it’s substantial enough that domestic wholesale is a viable model for resellers.
Is it legal to import peptides from China?
Importing research peptides from China for research-use-only resale is legal in the US when the products are properly classified and labeled. Customs friction varies by compound and shipment size. Random holds, document requests, and occasional seizures are part of the operational reality, not edge cases. This is not legal advice – consult an attorney for your specific situation.
What’s the cheapest peptide wholesaler?
The cheapest per-unit pricing always comes from Overseas Direct. But “cheapest per unit” rarely equals “cheapest total cost of doing business” once you account for inventory carrying costs, customs risk, payment friction, and the cost of stockouts. The wholesaler that produces the highest net margin for your specific business is almost never the one with the lowest sticker price. See the cash-flow section above for the framework.
How long does it take to get peptides from China?
10-15 days minimum from order to delivery, assuming clean customs clearance. Customs holds can extend this to 3-4 weeks with no advance warning and no recourse. Compare to 2-3 days domestic from a US-warehoused supplier.
Do US-based peptide manufacturers actually manufacture in the US?
Some do, some are US distributors holding inventory shipped in from overseas manufacturers. Both models can serve resellers well – what matters operationally is the US warehouse and the US-based sales team, not the original production geography. Ask any “US peptide manufacturer” where their warehouse and ship-from address is; that’s the meaningful answer.
Can I switch suppliers later?
Yes, and most successful operators end up with 2-3 supplier relationships by year 2 – typically a primary supplier for 80% of volume plus 1-2 secondary suppliers for specialty SKUs or backup. Switching requires re-testing quality consistency on your new supplier and potentially re-doing your COA library, so it’s not zero-cost. Plan to do it deliberately, not in panic.
The bottom line
For a new US-based operator running on a typical $10-15K launch budget, US-Based Wholesale almost always wins on the operational math, even though it loses on the per-unit math. The $3,000-4,000 of working capital you free up by not holding 4 weeks of inventory is more valuable than the 20-25% per-unit savings Overseas Direct would have offered – and you don’t have to absorb the customs risk, communication delay, and payment friction.
The exception is high-volume specialists – operators moving 500+ packs/mo of specific SKUs at year 2+. At that scale the math flips, and a mixed-supplier model usually makes sense.
If you’re trying to figure out where your specific situation lands – launch budget, target volume, SKU mix, geography – we do a free 20-minute intro call with founders evaluating this niche. No pitch, just honest input on what your supply chain math should look like.
Book at wwpeptides.com/vip-services/#book.
For the full framework on starting and running this kind of business, see our complete guide to peptide wholesale and our operator’s playbook for launching a peptide company.